Press Release
View printer-friendly version
Materialise Receives FDA NSE Letter for X-Ray 510(k) Submission
LEUVEN,
Wilfried Vancraen, Founder and CEO of Materialise states, “We are
disappointed that the
Cautionary Statement on Forward-Looking Statements
Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements relating to, among other things, our planned commercialization efforts and regulatory approvals of our technologies as well as the success thereof and our research and development projects. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control that may cause our actual results to differ materially from our expectations. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this presentation as a result of new information, future events or otherwise, unless we have obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.
About Materialise
With its headquarters in Leuven,
View source version on businesswire.com: http://www.businesswire.com/news/home/20151222005440/en/
Source:
Press:
Materialise NV
Vanessa Palsenbarg, +32
16 39 66 37
Corporate Communications Specialist, Materialise
press@materialise.com
Fax:
+32 16 39 66 00
Twitter: @belgiancanuck
or @MaterialiseNV
Visit:
www.materialise.com
or
Investors:
LHA
Harriet
Fried/Jody Burfening, 212-838-3777
hfried@lhai.com